{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:45:11Z","timestamp":1769723111149,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,11]]},"DOI":"10.7759\/cureus.85777","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:36:30Z","timestamp":1749656190000},"source":"Crossref","is-referenced-by-count":1,"title":["Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis"],"prefix":"10.7759","author":[{"given":"James","family":"Faraci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhbir","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.1070","article-title":"Light chain amyloidosis: epidemiology, staging, and prognostication","volume":"18","author":"Baker KR","year":"2022","unstructured":"Baker KR. Light chain amyloidosis: epidemiology, staging, and prognostication. Methodist Debakey Cardiovasc J. 2022, 18:27-35. 10.14797\/mdcvj.1070","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson MM","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, et al.. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020, 142:e7-e22. 10.1161\/CIR.0000000000000792","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini G","year":"2003","unstructured":"Palladini G, Campana C, Klersy C, et al.. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation. 2003, 107:2440-5. 10.1161\/01.CIR.0000068314.02595.B2","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro A","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018, 18:s30-5. 10.7861\/clinmedicine.18-2-s30","journal-title":"Clin Med (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25819","article-title":"Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment","volume":"95","author":"Gertz MA","year":"2020","unstructured":"Gertz MA. Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment. Am J Hematol. 2020, 95:848-60. 10.1002\/ajh.25819","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.62.1576","article-title":"Prognostic factors in light-chain cardiac amyloidosis: a retrospective analysis (Article in Japanese)","volume":"62","author":"Okumura H","year":"2021","unstructured":"Okumura H, Sato S, Kamata W, Tamai Y. Prognostic factors in light-chain cardiac amyloidosis: a retrospective analysis (Article in Japanese). Rinsho Ketsueki. 2021, 62:1576-82. 10.11406\/rinketsu.62.1576","journal-title":"Rinsho Ketsueki"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2022.12.006","article-title":"Clinical profile of patients with cardiac amyloidosis in India","volume":"75","author":"Mohan B","year":"2023","unstructured":"Mohan B, Singh S, Tandon R, et al.. Clinical profile of patients with cardiac amyloidosis in India. Indian Heart J. 2023, 75:73-6. 10.1016\/j.ihj.2022.12.006","journal-title":"Indian Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2022.13.7.5","article-title":"The role of echocardiogram and cardiac rhythm analysis for early detection of cardiac amyloidosis","volume":"13","author":"Hubert E","year":"2022","unstructured":"Hubert E, Dains JE. The role of echocardiogram and cardiac rhythm analysis for early detection of cardiac amyloidosis. J Adv Pract Oncol. 2022, 13:695-704. 10.6004\/jadpro.2022.13.7.5","journal-title":"J Adv Pract Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1081098","article-title":"Amyloidosis: what does pathology offer? The evolving field of tissue biopsy","volume":"9","author":"Riefolo M","year":"2022","unstructured":"Riefolo M, Conti M, Longhi S, Fabbrizio B, Leone O. Amyloidosis: what does pathology offer? The evolving field of tissue biopsy. Front Cardiovasc Med. 2022, 9:1081098. 10.3389\/fcvm.2022.1081098","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2020.05.062","article-title":"Abdominal fat biopsy for the diagnosis of cardiac amyloidosis","volume":"2","author":"Aimo A","year":"2020","unstructured":"Aimo A, Emdin M, Musetti V, Pucci A, Vergaro G. Abdominal fat biopsy for the diagnosis of cardiac amyloidosis. JACC Case Rep. 2020, 2:1182-5. 10.1016\/j.jaccas.2020.05.062","journal-title":"JACC Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01208-4","article-title":"Approach to the diagnosis of amyloidosis","volume":"36","author":"Juneja R","year":"2020","unstructured":"Juneja R, Pati HP. Approach to the diagnosis of amyloidosis. Indian J Hematol Blood Transfus. 2020, 36:246-53. 10.1007\/s12288-019-01208-4","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.03.012","article-title":"Treatment of AL amyloidosis: Mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement 2020 update","volume":"96","author":"Muchtar E","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Gertz MA, et al.. Treatment of AL amyloidosis: Mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement 2020 update. Mayo Clin Proc. 2021, 96:1546-77. 10.1016\/j.mayocp.2021.03.012","journal-title":"Mayo Clin Proc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar S","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al.. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012, 30:989-95. 10.1200\/JCO.2011.38.5724","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-based treatment for immunoglobulin light-chain amyloidosis","volume":"385","author":"Kastritis E","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, et al.. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med. 2021, 385:46-58. 10.1056\/NEJMoa2028631","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352616-atypical-presentation-of-systemic-amyloid-light-chain-al-amyloidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:36:31Z","timestamp":1749656191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352616-atypical-presentation-of-systemic-amyloid-light-chain-al-amyloidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.85777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}